Teva Pharmaceutical Industries (TEVA) Earnings Date, Estimates & Call Transcripts $16.83 -0.06 (-0.36%) Closing price 05/15/2025 03:53 PM EasternExtended Trading$17.48 +0.65 (+3.83%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Teva Pharmaceutical Industries Earnings Summary Teva Pharmaceutical Industries released Q1 2025 earnings on May 7, 2025, reporting an EPS of $0.52, which topped the consensus estimate of $0.47 by $0.05. Quarterly revenue rose 1.9% year-over-year to $3.89 billion, below analysts' expectations of $3.99 billion. With a trailing EPS of -$1.15, Teva Pharmaceutical Industries' earnings are expected to grow 5.20% next year, from $2.50 to $2.63 per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 7) $0.47 Actual EPS (May. 7) $0.52 Beat By $0.05 Actual Revenue (May. 7) $3.89BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Slide Deck Quarterly Report (10-Q)TEVA Upcoming EarningsTeva Pharmaceutical Industries' next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Teva Pharmaceutical Industries Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Teva Pharmaceutical Industries and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTEVA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TEVA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Teva Pharmaceutical Industries Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20251$0.48$0.48$0.48$4.0 B0.520 - 0.520$4.0 B - $4.0 BQ2 20252$0.61$0.61$0.61Q3 20252$0.71$0.71$0.71Q4 20251$0.69$0.69$0.69 FY 2025 6 $2.49 $2.49 $2.49 Q1 20261$0.47$0.47$0.47Q2 20261$0.60$0.60$0.60Q3 20261$0.78$0.78$0.78Q4 20261$0.70$0.70$0.70 FY 2026 4 $2.55 $2.55 $2.55 Q1 20271$0.60$0.60$0.60 Teva Pharmaceutical Industries Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/7/2025Q1 2025$0.47$0.52+$0.05$0.18$3.99B$3.89B1/29/2025Q4 2024$0.69$0.70+$0.01-$0.19$4.10B-7/31/2024Q2 2024$0.55$0.58+$0.03$1.91$3.99B$4.16B5/8/2024Q1 2024$0.49$0.46 -$0.03$1.04$3.70B$3.82B1/31/2024Q4 2023$0.73$0.98+$0.25$1.55$3.97B$4.46B11/8/2023Q3 2023$0.57$0.60+$0.03$1.09$3.73B$3.90B8/2/2023Q2 2023$0.52$0.54+$0.02$1.85$3.69B$3.88B Teva Pharmaceutical Industries Earnings - Frequently Asked Questions When is Teva Pharmaceutical Industries's earnings date? Teva Pharmaceutical Industries has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on TEVA's earnings history. What guidance has Teva Pharmaceutical Industries issued on next quarter's earnings? Teva Pharmaceutical Industries issued an update on its first quarter 2025 earnings guidance on Friday, March, 28th. The company provided earnings per share guidance of 0.520-0.520 for the period, compared to the consensus earnings per share estimate of 0.480. The company issued revenue guidance of $4.0 billion-$4.0 billion, compared to the consensus revenue estimate of $4.0 billion. Did Teva Pharmaceutical Industries beat their earnings estimates last quarter? In the previous quarter, Teva Pharmaceutical Industries (NYSE:TEVA) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.05. Learn more on analysts' earnings estimate vs. TEVA's actual earnings. How can I listen to Teva Pharmaceutical Industries's earnings conference call? The conference call for Teva Pharmaceutical Industries's latest earnings report can be listened to online. Listen to Conference Call How can I read Teva Pharmaceutical Industries's conference call transcript? The conference call transcript for Teva Pharmaceutical Industries's latest earnings report can be read online. Read Transcript How much revenue does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded annual revenue of $16.62 billion. How much profit does Teva Pharmaceutical Industries generate each year? Teva Pharmaceutical Industries (NYSE:TEVA) has a recorded net income of -$1.64 billion. TEVA has generated -$1.15 earnings per share over the last four quarters. What is Teva Pharmaceutical Industries's price-to-earnings ratio? Teva Pharmaceutical Industries (NYSE:TEVA) has a forward price-to-earnings ratio of 6.73. The price/earnings-to-growth ratio is 1.44. What is Teva Pharmaceutical Industries's EPS forecast for next year? Teva Pharmaceutical Industries's earnings are expected to grow from $2.50 per share to $2.63 per share in the next year, which is a 5.20% increase. More Earnings Resources from MarketBeat Related Companies GSK Earnings Results TAK Earnings Results ARGX Earnings Results BNTX Earnings Results ONC Earnings Results SMMT Earnings Results ITCI Earnings Results GMAB Earnings Results RDY Earnings Results VTRS Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NYSE:TEVA) was last updated on 5/16/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredCan This System Really Predict Stocks to the Day?Imagine foreseeing a 30% stock jump — to the day — weeks before it happens. Introducing a new way to predict t...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredLenin was right all along… It’s not often you hear praise for a Bolshevik from a veteran investor… but Porter Stansberry says Lenin got o...Porter & Company | SponsoredPrepare now for May 31 eventMUST SEE: Elon Musk's latest project He's one of the most controversial men on the planet. But the Tesla fo...Stansberry Research | Sponsored“America is running out of power” - The Washington PostAccording to The Washington Post, AI is causing America to “run out of power”... It’s true — utility compan...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TEVA Stock Free TEVA Stock Alerts